Literature DB >> 18536025

Origin of beta-cells in regenerating pancreas.

Kathy E O'Neill1, Daniel Eberhard, David Tosh.   

Abstract

The origin of insulin-expressing beta-cells in the adult mammalian pancreas is controversial. During normal tissue turnover and following injury, beta-cells may be replaced by duplication of existing beta-cells.1 However, an alternative source of beta-cells has recently been proposed based on neogenesis from a Ngn3-positive population present in regenerating pancreatic ducts.2 The appearance of beta-cells from Ngn3-positive progenitors is reminiscent of normal pancreas development, and Ngn3-expressing cells isolated from regenerating pancreas can generate the full repertoire of endocrine phenotypes. The isolation and characterisation of the equivalent human progenitors may represent a significant step forward in the hunt for a cure for diabetes. (c) 2008 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18536025     DOI: 10.1002/bies.20779

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  3 in total

1.  Direct in vivo cellular reprogramming involves transition through discrete, non-pluripotent steps.

Authors:  Jai Prakash Richard; Steven Zuryn; Nadine Fischer; Valeria Pavet; Nadège Vaucamps; Sophie Jarriault
Journal:  Development       Date:  2011-03-09       Impact factor: 6.868

2.  Therapy of experimental type 1 diabetes by isolated Sertoli cell xenografts alone.

Authors:  Francesca Fallarino; Giovanni Luca; Mario Calvitti; Francesca Mancuso; Claudio Nastruzzi; Maria C Fioretti; Ursula Grohmann; Ennio Becchetti; Anne Burgevin; Roland Kratzer; Peter van Endert; Louis Boon; Paolo Puccetti; Riccardo Calafiore
Journal:  J Exp Med       Date:  2009-10-12       Impact factor: 14.307

3.  Effect of Urtica dioica Leaf Alcoholic and Aqueous Extracts on the Number and the Diameter of the Islets in Diabetic Rats.

Authors:  Durdi Qujeq; Mohsen Tatar; Farideh Feizi; Hadi Parsian; Alieh Sohan Faraji; Sohrab Halalkhor
Journal:  Int J Mol Cell Med       Date:  2013
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.